Client News

  • 16th September 2019

    Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment

    Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease patients in a grey zone where the need for treatment is unclear. Coronary heart disease is a major cause of death worldwide and more than 7 million* people have a diagnosis in the UK alone. […]

  • 19th August 2019

    Herbicide resistance crisis targeted by new Oxford tech firm MoA Technology

    MoA Technology Limited, the crop protection discovery company, has secured £6.3m ($8m) Series A round to develop its unique crop protection discovery platforms in a bid to avert the global herbicide resistance crisis. Farmers across the world are now facing an increasingly difficult challenge: overuse of a small range of herbicides has led to increasing […]

  • 1st August 2019

    UK AI RegTech, FNA, announces $5.5m Series A funding to drive global risk reduction

    FNA today announces closure of a $5.5m Series A investment round led by IQ Capital, with participation from GETTYLAB. The funds will be used to further develop the FNA platform and solutions to help financial regulators and institutions operationalize advanced data analytics, identify fault lines in the financial system and prepare better for financial crisis […]

  • 30th July 2019

    GCHQ accelerator alumni CyberSmart raises £1.3M VC funding to accelerate growth

    CyberSmart, a GCHQ Cyber Accelerator alumni, has secured £1.3 million in new financing led by deep-tech investor IQ Capital, after two years in stealth mode. This funding will allow CyberSmart to further accelerate its rapid growth, build next-generation technical capabilities and secure Britain’s future as a leader in cybersecurity.   CyberSmart’s core mission is to […]

  • 30th July 2019

    PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product pipeline

    PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced the completion of its Series B funding having raised £10M. The investment cements PredictImmune’s solid financial position, enabling it to build on the successful launch of its first product, PredictSURE IBD™, with a major focus on […]

Let's get started

If you'd like to work with us,
we'd love to hear from you

FieldHouse Associates

2nd Floor
Monmouth House
5 Shelton Street
London
WC2H 9JW

85 Regent Street
Cambridge
CB2 1AW